GLP-1 users spur growing hair treatment market over temporary hair loss
Updated
Updated · CNBC · May 2
GLP-1 users spur growing hair treatment market over temporary hair loss
15 articles · Updated · CNBC · May 2
U.S. uptake is surging: nearly 13% of adults use GLP-1 drugs, and JPMorgan projects 25 million Americans on them by 2030.
Researchers and dermatologists say rapid weight loss, lower nutrient intake and bodily stress can trigger shedding, while Circana says GLP-1 households spend about 30% more on beauty products.
Brands including Redken, Nutrafol and KeraFactor are targeting demand with scalp and growth products, as users report the side effect is distressing but often temporary and reversible.
With millions using GLP-1s, is our rush for quick fixes like hair supplements masking deeper health or psychological challenges from rapid weight loss?
If hair loss from GLP-1s is often temporary, are beauty brands overpromising results, or is there a more effective medical approach being overlooked?
Could the surge in beauty and supplement sales for GLP-1 users reveal more about our society's priorities than about the drugs themselves?